VSee Co-CEO repays loans with company stock

VSee Health, Inc. director and Co-Chief Executive Officer Aisiku Imoigele reported two stock transfers used to repay personal loans.

Accepted by SEC EDGAR 02/19/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

VSee Health, Inc. director and Co-Chief Executive Officer Aisiku Imoigele reported two stock transfers used to repay personal loans. On August 15, he transferred 25,000 common shares at $2.00 per share in full satisfaction of a $50,000 personal loan. On August 14, he transferred 100,000 common shares at $2.00 per share to board member David Wickersham to fully repay a separate $200,000 personal loan made to him by Mr. Wickersham. Following these transactions, his reported direct holdings remained above 3.2 million common shares.

Insider Trade Summary

Other: 125,000 shares

Other 2 txns

Insider Aisiku Imoigele

Role Co-Chief Executive Officer

Type	Security	Shares	Price	Value
Other	Common Stock, par value $0.0001 per share	25,000	$2.00	$50K
Other	Common Stock, par value $0.0001 per share	100,000	$2.00	$200K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 3,256,621 shares (Direct)

Footnotes (2)

1. F1. The reporting person transferred the shares in full satisfaction of a personal loan in the amount of $50,000 that was made to the reporting person by the transferee of the shares.
2. F2. The reporting person transferred the shares to David Wickersham, a member of the Board of Directors of the issuer, in full satisfaction of a personal loan in the amount of $200,000 that was made to the reporting person by Mr. Wickersham.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VSEE Co-CEO Aisiku Imoigele report?

Aisiku Imoigele reported two transfers of VSEE common stock classified as “other” transactions. He used these share transfers to fully satisfy outstanding personal loans totaling $250,000 owed to a lender and to director David Wickersham.

How many VSEE shares did Aisiku Imoigele transfer in the Form 4?

He transferred a total of 125,000 VSEE common shares. This included 25,000 shares on August 15, valued at $2.00 per share, and 100,000 shares on August 14, also valued at $2.00 per share, according to the Form 4.

What loans were repaid through the VSEE share transfers?

The share transfers repaid two personal loans to Aisiku Imoigele. One transfer satisfied a $50,000 loan from a share transferee, and a second transfer repaid a $200,000 personal loan from director David Wickersham, fully discharging both obligations.

How were the VSEE share transfers to David Wickersham described?

The Form 4 states that Aisiku Imoigele transferred shares to David Wickersham, a VSee Health director, in full satisfaction of a $200,000 personal loan. The transaction was coded “J” as an other acquisition or disposition of non-derivative common stock.

What was the reported price per VSEE share in these insider transactions?

Both transactions used a reported price of $2.00 per VSEE common share. This price applied to the 25,000-share transfer linked to a $50,000 loan and to the 100,000-share transfer linked to the $200,000 loan to David Wickersham.

Did Aisiku Imoigele retain a significant VSEE shareholding after these transfers?

Yes. After the reported transactions, his direct ownership remained above 3.2 million common shares. The Form 4 shows totals exceeding 3,256,000 and 3,281,000 shares following the respective transactions, indicating he continues to hold a large equity position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aisiku Imoigele

(Last) (First) (Middle)

C/O VSEE HEALTH, INC.

980 N FEDERAL HWY #304

(Street)

BOCA RATON FL 33432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VSEE HEALTH, INC. [ VSEE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	08/15/2025		J(1)		25,000	D	$2	3,256,621	D
Common Stock, par value $0.0001 per share	08/14/2025		J(2)		100,000	D	$2	3,281,621	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person transferred the shares in full satisfaction of a personal loan in the amount of $50,000 that was made to the reporting person by the transferee of the shares.

2. The reporting person transferred the shares to David Wickersham, a member of the Board of Directors of the issuer, in full satisfaction of a personal loan in the amount of $200,000 that was made to the reporting person by Mr. Wickersham.

	/s/ Imoigele Aisiku	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.